Pharmaceutical companies conduct clinical trials for many reasons. The most obvious goal of clinical trials is to demonstrate safety and efficacy to gain Food and Drug Administration (FDA) approval. FDA provides guidance to developers about what constitutes acceptable clinical trials and appropriate outcomes.
Medical Product Development
Reports
Displaying 21 - 26 of 26. 10 per page. Page 3.
Advanced SearchAnalytical Framework for Examining the Value of Antibacterial Products
Antibacterial resistance is a growing global problem. At least 2 million people in the U.S. acquire serious infections with bacteria that are resistant to one or more of antibacterial drugs designed to treat it.
Health Care Cost Containment and Medical Innovation
ASPE ISSUE BRIEF Health Care Cost Containment and Medical Innovation May 2012 By: Amber Jessup, Ph.D.
Economic Analysis of Availability of Follow-on Protein Products
Contract HHSP23320045017XI Task Order HHSP233200700003T Prepared for: Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation Prepared by:
Cost Effectiveness Considerations in the Approval and Adoption of New Health Technologies
Contents Background and Purpose Methodology Summary of Key Findings and Stakeholder Suggestions Conclusions and Policy Implications A.
Health Care in Transition: Technology Assessment in the Private Sector
Health Care in Transition: Technology Assessment in the Private Sector Prepared by: Richard Rettig of the RAND Corporation Office of the Assistant Secretary of Planning and Evaluation Agency for Health Care Policy and Research. July, 1996.